Max Planck Institute
Chariteplatz 1
Campus Charite Mitte
Berlin
D-10117
Germany
Tel: 49-30-28-4600
Fax: 49-30-28-460141
74 articles about Max Planck Institute
-
Max Planck Institute of Biochemistry, Lead Discovery Center and Qurient Close License Deal on a New Compound Against Metastatic and Drug-Resistant Cancers
3/12/2013
-
Real-Life "Love Potion" ID'd, Max Planck Institute Study
1/29/2013
-
Why Musical Genius Comes Easier to Early Starters, Max Planck Institute Study
1/17/2013
-
Public's Big Gamble on Max Planck Institute to be Put to the Test; Now Hiring
12/5/2012
-
Musical Duets Lock Brains As Well As Rhythms, Max Planck Institute Study
11/29/2012
-
New Insights Into Virus Proteome: Unknown Proteins of the Herpesvirus Discovered, Max Planck Institute and University of California, San Francisco (UCSF) Study
11/26/2012
-
Dyslexia May be Caused by Signal Processing Problem in Brain, Max Planck Institute Study
8/13/2012
-
Dopamine: A Substance With Many Messages, Max Planck Institute Study
7/19/2012
-
Bonobo Genome Completed: The Final Great Ape to Be Sequenced, Max Planck Institute Study
6/14/2012
-
Free-Electron Lasers Reveal Detailed Architecture of Proteins, Max Planck Institute Study
6/1/2012
-
Researchers Develop New Method for the Production of Microlenses, Max Planck Institute Study
3/26/2012
-
Somatic Stem Cells Obtained From Skin Cells for First Time Ever, Max Planck Institute Study
3/23/2012
-
Max Planck Institute Biotech Lab Selling Naming Rights
3/14/2012
-
Sperm Can Do Calculus! Max Planck Institute Study
3/8/2012
-
Self-Centered Kids May Just Have Immature Brains, Max Planck Institute Study
3/8/2012
-
Two Molecules Communicate Via Single Photons, Max Planck Institute Study
2/29/2012
-
Short-Term Memory is Based on Synchronized Brain Oscillations, Max Planck Institute Study
2/1/2012
-
Scientists Use Silk From the Tasar Silkworm As a Scaffold for Heart Tissue, Max Planck Institute Study
1/31/2012
-
Biovest International, Inc. Collaborates with Max Planck Institute to Advance its Hollow Fiber Bioreactors for the Manufacture of Viral Vaccines
1/12/2012
-
QIAGEN N.V. and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
1/9/2012